Skip to main content
. 2007 Aug;16(4):266–270. doi: 10.1136/qshc.2006.020164

Table 1 Impact of the new policy on the interactions between general practitioners and pharmaceutical sales representatives (PSRs).

Preintervention Postintervention (3 months) Postintervention (9 months)
Doctor visits with PSRs in 1 month
 PSR visits booked in doctors' diaries 16 0 0
 Reported corridor visits 12 2 0
No. of promotional items (mean/room) at the Inala Health Centre General Practice
 Doctors rooms (n = 5) 148 (29.6) 112 (22.4) 120 (24)
 Total administration area (n = 2) 38 (19) 27 (13.5) 26 (13)
 Total nursing area (n = 7) 25 (8.3) 14 (2) 37 (5.3)
 Total other areas (n = 5) 28 (5.6) 10 (2) 6 (1.2)
 Total 239 (12.6) 163 (8.6)* 189 (10.0)†
Sample cupboard items (tablets/capsules/tubes/bottles) 4660 1902 1389
Prescribing patterns (based on 1 week of practice prescribing data at each time period)
 Patient encounters 547 504 530
 Number of prescriptions (total) 542 464 285
 Prescriptions per patient encounter 0.99 0.92 0.54
 Generic prescriptions (% of total prescriptions) 4 8.6‡ 8.1§

*3‐month postintervention audit compared with preintervention: −76 items (−4.0 items/room; 95% CI −6.61 to −1.39); Kruskal–Wallis H test = 14.7, df = 8, p = 0.066.

†9‐month postintervention audit compared with preintervention: −50 items (−2.63 items/room; 95% CI −5.86 to 0.60); Kruskal–Wallis H test = 13.9, df = 11, p = 0.24.

‡3‐month postintervention audit compared with preintervention: odds ratio 2.28 (95% CI 1.31 to 3.86); χ2 test = 8.99, df = 1, p = 0.0027.

§9‐month postintervention audit compared with preintervention: odds ratio 2.07 (95% CI 1.13 to 3.82); χ2 test = 5.84, df = 1, p = 0.016.